Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000260290 is a pseudogene derived from the NONO gene, which encodes the Non-POU domain-containing octamer-binding protein (NONO)[7]. Pseudogenes are DNA segments that resemble functional genes but have lost the ability to encode a functional protein, often due to mutations such as frameshifts or premature stop codons[1][3]. The parent NONO gene is involved in nuclear functions including transcription regulation, RNA splicing, and has roles in circadian rhythm and cancer biology[4][6]. However, ENSG00000260290 does not produce a protein and is not considered a direct therapeutic target or biomarker. ENSG00000260290 is not a therapeutically relevant protein or receptor. It is a pseudogene—a sequence related to the NONO gene but incapable of producing the functional NonO protein[7][1][3]. Information regarding the functional NONO gene should not be directly attributed to this pseudogene unless specifically validated by studies.
None, as it is not a drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Non-POU domain containing, octamer-binding pseudogene.